Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 128

1.

New concepts in axillary management of breast cancer.

Atalay C.

World J Clin Oncol. 2014 Dec 10;5(5):895-900. doi: 10.5306/wjco.v5.i5.895. Review.

PMID:
25493227
[PubMed]
Free PMC Article
2.

Feasibility and accuracy of sentinel lymph node biopsy in clinically node-positive breast cancer after neoadjuvant chemotherapy: a meta-analysis.

Fu JF, Chen HL, Yang J, Yi CH, Zheng S.

PLoS One. 2014 Sep 11;9(9):e105316. doi: 10.1371/journal.pone.0105316. eCollection 2014.

PMID:
25210779
[PubMed - in process]
Free PMC Article
3.

Clinicopathologic subtypes and compromise of lymph nodes in patients with breast cancer.

Jaime Jans B, Nicolás Escudero M, Dahiana Pulgar B, Francisco Acevedo C, César Sánchez R, Camus AM.

Ecancermedicalscience. 2014 Jul 23;8:448. doi: 10.3332/ecancer.2014.448. eCollection 2014.

PMID:
25114720
[PubMed]
Free PMC Article
4.

A new model for predicting non-sentinel lymph node status in Chinese sentinel lymph node positive breast cancer patients.

Liu M, Wang S, Pan L, Yang D, Xie F, Liu P, Guo J, Zhang J, Zhou B.

PLoS One. 2014 Aug 11;9(8):e104117. doi: 10.1371/journal.pone.0104117. eCollection 2014.

PMID:
25111296
[PubMed - in process]
Free PMC Article
5.

Mapping lymph nodes in cancer management - role of (99m)Tc-tilmanocept injection.

Tausch C, Baege A, Rageth C.

Onco Targets Ther. 2014 Jun 24;7:1151-8. doi: 10.2147/OTT.S50394. eCollection 2014. Review.

PMID:
25028560
[PubMed]
Free PMC Article
6.

Sentinel node biopsy and axillary dissection in breast cancer: the evidence and its limits.

Janni W, Kühn T, Schwentner L, Kreienberg R, Fehm T, Wöckel A.

Dtsch Arztebl Int. 2014 Apr 4;111(14):244-9. doi: 10.3238/arztebl.2014.0244.

PMID:
24766712
[PubMed - in process]
Free PMC Article
7.

Axillary Lymph Node Status in Early-Stage Breast Cancer Patients with Sentinel Node Micrometastases (0.2-2 mm).

Bargehr J, Edlinger M, Hubalek M, Marth C, Reitsamer R.

Breast Care (Basel). 2013 Jun;8(3):187-91. doi: 10.1159/000352090.

PMID:
24415968
[PubMed]
Free PMC Article
8.

Sentinel nodes identified by computed tomography-lymphography accurately stage the axilla in patients with breast cancer.

Motomura K, Sumino H, Noguchi A, Horinouchi T, Nakanishi K.

BMC Med Imaging. 2013 Dec 9;13:42. doi: 10.1186/1471-2342-13-42.

PMID:
24321242
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Underscoring the influence of inorganic chemistry on nuclear imaging with radiometals.

Zeglis BM, Houghton JL, Evans MJ, Viola-Villegas N, Lewis JS.

Inorg Chem. 2014 Feb 17;53(4):1880-99. doi: 10.1021/ic401607z. Epub 2013 Dec 6.

PMID:
24313747
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Number of Axillary Lymph Node Metastases Determined by Preoperative Ultrasound is Related to Prognosis in Patients with Breast Cancer.

Kijima Y, Yoshinaka H, Hirata M, Mizoguchi T, Ishigami S, Nakajo A, Arima H, Ueno S, Natsugoe S.

Cancers (Basel). 2010 Feb 4;2(1):20-31. doi: 10.3390/cancers2010020.

PMID:
24281030
[PubMed]
Free PMC Article
11.

Correlation between the area of high-signal intensity on SPIO-enhanced MR imaging and the pathologic size of sentinel node metastases in breast cancer patients with positive sentinel nodes.

Motomura K, Izumi T, Tateishi S, Sumino H, Noguchi A, Horinouchi T, Nakanishi K.

BMC Med Imaging. 2013 Sep 13;13:32. doi: 10.1186/1471-2342-13-32.

PMID:
24028426
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Current status and future perspectives on minimally invasive esophagectomy.

Kawakubo H, Takeuchi H, Kitagawa Y.

Korean J Thorac Cardiovasc Surg. 2013 Aug;46(4):241-8. doi: 10.5090/kjtcs.2013.46.4.241. Epub 2013 Aug 6. Review.

PMID:
24003404
[PubMed]
Free PMC Article
13.

A brief account of nanoparticle contrast agents for photoacoustic imaging.

Pan D, Kim B, Wang LV, Lanza GM.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2013 Nov-Dec;5(6):517-43. doi: 10.1002/wnan.1231. Epub 2013 Aug 23. Review.

PMID:
23983210
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Inhibition of VEGF-C modulates distal lymphatic remodeling and secondary metastasis.

Gogineni A, Caunt M, Crow A, Lee CV, Fuh G, van Bruggen N, Ye W, Weimer RM.

PLoS One. 2013 Jul 16;8(7):e68755. doi: 10.1371/journal.pone.0068755. Print 2013.

PMID:
23874750
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Imaging lymphatic system in breast cancer patients with magnetic resonance lymphangiography.

Lu Q, Hua J, Kassir MM, Delproposto Z, Dai Y, Sun J, Haacke M, Hu J.

PLoS One. 2013 Jul 5;8(7):e69701. doi: 10.1371/journal.pone.0069701. Print 2013.

PMID:
23861979
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

A Green Synthesis of Carbon Nanoparticle from Honey for Real-Time Photoacoustic Imaging.

Wu L, Cai X, Nelson K, Xing W, Xia J, Zhang R, Stacy AJ, Luderer M, Lanza GM, Wang LV, Shen B, Pan D.

Nano Res. 2013;6(5):312-325.

PMID:
23824757
[PubMed]
Free PMC Article
17.

Feasibility of sentinel lymph node biopsy in breast cancer patients clinically suspected of axillary lymph node metastasis on preoperative imaging.

Kwak HY, Chae BJ, Bae JS, Kim EJ, Chang EY, Kim SH, Jung SS, Song BJ.

World J Surg Oncol. 2013 May 21;11:104. doi: 10.1186/1477-7819-11-104.

PMID:
23693028
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Sentinel Lymph Node Biopsy for Breast Cancer: Our Technique and Future Directions in Lymph Node Staging.

Rashid OM, Takabe K.

J Nucl Med Radiat Ther. 2012 May 28;2012(S2). pii: 005.

PMID:
23513181
[PubMed]
Free PMC Article
19.

Comparative evaluation of [(99m)tc]tilmanocept for sentinel lymph node mapping in breast cancer patients: results of two phase 3 trials.

Wallace AM, Han LK, Povoski SP, Deck K, Schneebaum S, Hall NC, Hoh CK, Limmer KK, Krontiras H, Frazier TG, Cox C, Avisar E, Faries M, King DW, Christman L, Vera DR.

Ann Surg Oncol. 2013 Aug;20(8):2590-9. doi: 10.1245/s10434-013-2887-8. Epub 2013 Mar 17.

PMID:
23504141
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial.

Galimberti V, Cole BF, Zurrida S, Viale G, Luini A, Veronesi P, Baratella P, Chifu C, Sargenti M, Intra M, Gentilini O, Mastropasqua MG, Mazzarol G, Massarut S, Garbay JR, Zgajnar J, Galatius H, Recalcati A, Littlejohn D, Bamert M, Colleoni M, Price KN, Regan MM, Goldhirsch A, Coates AS, Gelber RD, Veronesi U; International Breast Cancer Study Group Trial 23-01 investigators.

Lancet Oncol. 2013 Apr;14(4):297-305. doi: 10.1016/S1470-2045(13)70035-4. Epub 2013 Mar 11. Erratum in: Lancet Oncol. 2013 Jun;14(7):e254.

PMID:
23491275
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk